SlideShare ist ein Scribd-Unternehmen logo
1 von 18
Symposium 3: BA/BE The Proof of Concept ,[object Object],[object Object],[object Object]
PRACTICAL ASPECTS of BIOEQUIVALENCE STUDIES For  the TUFTAD Session:  BA/BE The Proof of Concept Prof.Dr.A. Atilla HINCAL Hacettepe University Faculty of Pharmacy Sıhhiye 06100 Ankara,Turkey International Congress “PharmaCon2007”on New Technologies&Trends  in Pharmaceutical Industry and Education,  Dubrovnik,Croatia,  May 22-27, 2007 This session  is sponsored by
Bioequivalence Studies  of a Product ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Characteristics of a BE Study ,[object Object],[object Object],[object Object],[object Object]
Required stages of a product before it reaches the patient ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Necessities for a new product ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
What is required to carry out these studies? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The Management of the  BE studies  ,[object Object],[object Object]
Review Process for Brand Name and Generic Drug ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
What are the requirements for a generic product ? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
BA/BE studies organization platform SPONSOR (Manufacturer) CLINICAL STUDIES (Accredited Centers,  Analytical CRO’s) BIOANALYTICAL STUDIES (Accredited Centers,  Analytical CRO’s) SCIENTIFIC  CONTRACT SERVICE  ORGANIZATION HEALTH AUTHORITY   LOCAL ETHICAL COMMITTEE Candidate Product  for BE CENTRAL ETHICAL COMMITTEE
Some Important Details About BE Studies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],Conclusion  1 ,[object Object],[object Object],[object Object],[object Object]
Conclusion  2 ,[object Object],[object Object]
Conclusion  3 CSO s  and CROs that have long time experience have cumulated knowledge and talent for a specific project management in BE studies. It is possible for such an experienced and established CSO/CRO to reduce the expenses of the sponsor pharmaceutical company, to avoid loss of sources and to optimize the use of time.
Final remarks for the young colleagues ,[object Object],[object Object],[object Object]
Acknowledgement
[object Object]

Weitere ähnliche Inhalte

Was ist angesagt?

5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.Audumbar Mali
 
Investigational New drug application [INDA]
Investigational New drug application [INDA]Investigational New drug application [INDA]
Investigational New drug application [INDA]Sagar Savale
 
New Drug Application [NDA]
New Drug Application [NDA]New Drug Application [NDA]
New Drug Application [NDA]Sagar Savale
 
Investigation of medicinal product dossier (IMPD)
Investigation of medicinal product dossier (IMPD)Investigation of medicinal product dossier (IMPD)
Investigation of medicinal product dossier (IMPD)Himal Barakoti
 
21 Code of Federal Regulation(21-CFR)
21 Code of Federal Regulation(21-CFR)21 Code of Federal Regulation(21-CFR)
21 Code of Federal Regulation(21-CFR)AshishVerma593
 
Clinical trial protocol development
Clinical trial protocol developmentClinical trial protocol development
Clinical trial protocol developmentSACHIN C P
 
4. Unit-IV:- Clinical Trials.
4. Unit-IV:- Clinical Trials.4. Unit-IV:- Clinical Trials.
4. Unit-IV:- Clinical Trials.Audumbar Mali
 
Clinical Trial Protocol.pptx
Clinical Trial Protocol.pptxClinical Trial Protocol.pptx
Clinical Trial Protocol.pptxVenugopal N
 
Clinical research protocols
Clinical research protocolsClinical research protocols
Clinical research protocolsMouryaDeep
 
Investigator's Brochure
Investigator's BrochureInvestigator's Brochure
Investigator's BrochureRiyaz Gohil
 
Code of federal regulations {cfr} in pharmaceutical
Code of federal regulations {cfr} in pharmaceuticalCode of federal regulations {cfr} in pharmaceutical
Code of federal regulations {cfr} in pharmaceuticalArabinda Changmai
 
Non clinical drug development. ppt
Non clinical drug development. pptNon clinical drug development. ppt
Non clinical drug development. pptPRABU12345678
 
ANDA regulatory approval process
ANDA regulatory approval processANDA regulatory approval process
ANDA regulatory approval processROHIT
 
Hatch waxman act & amendments ppt
Hatch waxman act & amendments  pptHatch waxman act & amendments  ppt
Hatch waxman act & amendments pptAlexa Jacob
 
IND INDA ANDA Application
IND INDA ANDA ApplicationIND INDA ANDA Application
IND INDA ANDA ApplicationRoshan Bodhe
 
Investigational New Drug Application
Investigational New Drug ApplicationInvestigational New Drug Application
Investigational New Drug ApplicationSuhas Reddy C
 

Was ist angesagt? (20)

5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.
 
Investigational New drug application [INDA]
Investigational New drug application [INDA]Investigational New drug application [INDA]
Investigational New drug application [INDA]
 
Orange book
Orange bookOrange book
Orange book
 
New Drug Application [NDA]
New Drug Application [NDA]New Drug Application [NDA]
New Drug Application [NDA]
 
Investigation of medicinal product dossier (IMPD)
Investigation of medicinal product dossier (IMPD)Investigation of medicinal product dossier (IMPD)
Investigation of medicinal product dossier (IMPD)
 
21 Code of Federal Regulation(21-CFR)
21 Code of Federal Regulation(21-CFR)21 Code of Federal Regulation(21-CFR)
21 Code of Federal Regulation(21-CFR)
 
Clinical trial protocol development
Clinical trial protocol developmentClinical trial protocol development
Clinical trial protocol development
 
4. Unit-IV:- Clinical Trials.
4. Unit-IV:- Clinical Trials.4. Unit-IV:- Clinical Trials.
4. Unit-IV:- Clinical Trials.
 
Clinical Trial Protocol.pptx
Clinical Trial Protocol.pptxClinical Trial Protocol.pptx
Clinical Trial Protocol.pptx
 
Clinical research protocols
Clinical research protocolsClinical research protocols
Clinical research protocols
 
Investigator's Brochure
Investigator's BrochureInvestigator's Brochure
Investigator's Brochure
 
Code of federal regulations {cfr} in pharmaceutical
Code of federal regulations {cfr} in pharmaceuticalCode of federal regulations {cfr} in pharmaceutical
Code of federal regulations {cfr} in pharmaceutical
 
Non clinical drug development. ppt
Non clinical drug development. pptNon clinical drug development. ppt
Non clinical drug development. ppt
 
ANDA regulatory approval process
ANDA regulatory approval processANDA regulatory approval process
ANDA regulatory approval process
 
COPP.pptx
COPP.pptxCOPP.pptx
COPP.pptx
 
MHRA
MHRAMHRA
MHRA
 
Hatch waxman act & amendments ppt
Hatch waxman act & amendments  pptHatch waxman act & amendments  ppt
Hatch waxman act & amendments ppt
 
CTD and eCTD
CTD and eCTDCTD and eCTD
CTD and eCTD
 
IND INDA ANDA Application
IND INDA ANDA ApplicationIND INDA ANDA Application
IND INDA ANDA Application
 
Investigational New Drug Application
Investigational New Drug ApplicationInvestigational New Drug Application
Investigational New Drug Application
 

Ähnlich wie Significance of BA/BE studies in drug research and evaluation of different aspects

Outsourcing BA and BE to CRO
Outsourcing BA and BE to CROOutsourcing BA and BE to CRO
Outsourcing BA and BE to CRODhanshreeBhattad
 
A.Clinical trails.pptx
A.Clinical trails.pptxA.Clinical trails.pptx
A.Clinical trails.pptxDhanaa Dhoni
 
Biosimilars: Regulatory and Clinical Considerations
Biosimilars: Regulatory and Clinical ConsiderationsBiosimilars: Regulatory and Clinical Considerations
Biosimilars: Regulatory and Clinical ConsiderationsCovance
 
Accelerating Generic Approvals by Dr Anthony Crasto
Accelerating Generic Approvals by Dr Anthony CrastoAccelerating Generic Approvals by Dr Anthony Crasto
Accelerating Generic Approvals by Dr Anthony CrastoAnthony Melvin Crasto Ph.D
 
OUTSOURCING TO BE AND BA final.pptx
OUTSOURCING TO BE AND BA final.pptxOUTSOURCING TO BE AND BA final.pptx
OUTSOURCING TO BE AND BA final.pptxManojKumarr75
 
OUT SOURCING BA AND BE TO CRO.pdf
OUT SOURCING BA AND BE TO CRO.pdfOUT SOURCING BA AND BE TO CRO.pdf
OUT SOURCING BA AND BE TO CRO.pdfNONE
 
Chap2 CTPMR, 2nd Ed. 2016
Chap2 CTPMR, 2nd Ed. 2016Chap2 CTPMR, 2nd Ed. 2016
Chap2 CTPMR, 2nd Ed. 2016Eric Dollins
 
CHI's Immunogenicity and Bioassay Summit 2015
CHI's Immunogenicity and Bioassay Summit 2015CHI's Immunogenicity and Bioassay Summit 2015
CHI's Immunogenicity and Bioassay Summit 2015James Prudhomme
 
BioSimilar Drug Development World
BioSimilar Drug Development WorldBioSimilar Drug Development World
BioSimilar Drug Development WorldGeneric Pharma 2.0
 
OUTSOURCING OF BA and BE TO CRO .pptx
OUTSOURCING OF BA and BE TO CRO .pptxOUTSOURCING OF BA and BE TO CRO .pptx
OUTSOURCING OF BA and BE TO CRO .pptxPawanDhamala1
 
Legochem Company ppt
Legochem Company pptLegochem Company ppt
Legochem Company ppttheeastrd
 
Pharmaceutical preformulation and formulation
Pharmaceutical preformulation  and formulationPharmaceutical preformulation  and formulation
Pharmaceutical preformulation and formulationSuchandra03
 
A biosimilar industry view on the implementation of the who guidelines on eva...
A biosimilar industry view on the implementation of the who guidelines on eva...A biosimilar industry view on the implementation of the who guidelines on eva...
A biosimilar industry view on the implementation of the who guidelines on eva...National Institute of Biologics
 
A biosimilar industry view on the implementation of the WHO guidelines on eva...
A biosimilar industry view on the implementation of the WHO guidelines on eva...A biosimilar industry view on the implementation of the WHO guidelines on eva...
A biosimilar industry view on the implementation of the WHO guidelines on eva...National Institute of Biologics
 
10th Annual Bioassays and Bioanalytical Method Development Conference Report ...
10th Annual Bioassays and Bioanalytical Method Development Conference Report ...10th Annual Bioassays and Bioanalytical Method Development Conference Report ...
10th Annual Bioassays and Bioanalytical Method Development Conference Report ...Doranelly (Dolly) Koltchev
 
ICH GCP GUIDELINES FOR CONDUCT OF TRIAL
ICH GCP GUIDELINES FOR CONDUCT OF TRIALICH GCP GUIDELINES FOR CONDUCT OF TRIAL
ICH GCP GUIDELINES FOR CONDUCT OF TRIALMOHAMMED FAHEEM KHAN
 
College Writing II Synthesis Essay Assignment Summer Semester 2017.docx
College Writing II Synthesis Essay Assignment Summer Semester 2017.docxCollege Writing II Synthesis Essay Assignment Summer Semester 2017.docx
College Writing II Synthesis Essay Assignment Summer Semester 2017.docxclarebernice
 

Ähnlich wie Significance of BA/BE studies in drug research and evaluation of different aspects (20)

40718
4071840718
40718
 
Outsourcing BA and BE to CRO
Outsourcing BA and BE to CROOutsourcing BA and BE to CRO
Outsourcing BA and BE to CRO
 
A.Clinical trails.pptx
A.Clinical trails.pptxA.Clinical trails.pptx
A.Clinical trails.pptx
 
Biosimilars: Regulatory and Clinical Considerations
Biosimilars: Regulatory and Clinical ConsiderationsBiosimilars: Regulatory and Clinical Considerations
Biosimilars: Regulatory and Clinical Considerations
 
Accelerating Generic Approvals by Dr Anthony Crasto
Accelerating Generic Approvals by Dr Anthony CrastoAccelerating Generic Approvals by Dr Anthony Crasto
Accelerating Generic Approvals by Dr Anthony Crasto
 
BBCR Innovation Approach
BBCR Innovation ApproachBBCR Innovation Approach
BBCR Innovation Approach
 
OUTSOURCING TO BE AND BA final.pptx
OUTSOURCING TO BE AND BA final.pptxOUTSOURCING TO BE AND BA final.pptx
OUTSOURCING TO BE AND BA final.pptx
 
OUT SOURCING BA AND BE TO CRO.pdf
OUT SOURCING BA AND BE TO CRO.pdfOUT SOURCING BA AND BE TO CRO.pdf
OUT SOURCING BA AND BE TO CRO.pdf
 
Chap2 CTPMR, 2nd Ed. 2016
Chap2 CTPMR, 2nd Ed. 2016Chap2 CTPMR, 2nd Ed. 2016
Chap2 CTPMR, 2nd Ed. 2016
 
CHI's Immunogenicity and Bioassay Summit 2015
CHI's Immunogenicity and Bioassay Summit 2015CHI's Immunogenicity and Bioassay Summit 2015
CHI's Immunogenicity and Bioassay Summit 2015
 
BioSimilar Drug Development World
BioSimilar Drug Development WorldBioSimilar Drug Development World
BioSimilar Drug Development World
 
OUTSOURCING OF BA and BE TO CRO .pptx
OUTSOURCING OF BA and BE TO CRO .pptxOUTSOURCING OF BA and BE TO CRO .pptx
OUTSOURCING OF BA and BE TO CRO .pptx
 
Legochem Company ppt
Legochem Company pptLegochem Company ppt
Legochem Company ppt
 
Pharmaceutical preformulation and formulation
Pharmaceutical preformulation  and formulationPharmaceutical preformulation  and formulation
Pharmaceutical preformulation and formulation
 
A biosimilar industry view on the implementation of the who guidelines on eva...
A biosimilar industry view on the implementation of the who guidelines on eva...A biosimilar industry view on the implementation of the who guidelines on eva...
A biosimilar industry view on the implementation of the who guidelines on eva...
 
A biosimilar industry view on the implementation of the WHO guidelines on eva...
A biosimilar industry view on the implementation of the WHO guidelines on eva...A biosimilar industry view on the implementation of the WHO guidelines on eva...
A biosimilar industry view on the implementation of the WHO guidelines on eva...
 
10th Annual Bioassays and Bioanalytical Method Development Conference Report ...
10th Annual Bioassays and Bioanalytical Method Development Conference Report ...10th Annual Bioassays and Bioanalytical Method Development Conference Report ...
10th Annual Bioassays and Bioanalytical Method Development Conference Report ...
 
ICH GCP GUIDELINES FOR CONDUCT OF TRIAL
ICH GCP GUIDELINES FOR CONDUCT OF TRIALICH GCP GUIDELINES FOR CONDUCT OF TRIAL
ICH GCP GUIDELINES FOR CONDUCT OF TRIAL
 
Cr and opportunities by bhumika
Cr and opportunities by bhumikaCr and opportunities by bhumika
Cr and opportunities by bhumika
 
College Writing II Synthesis Essay Assignment Summer Semester 2017.docx
College Writing II Synthesis Essay Assignment Summer Semester 2017.docxCollege Writing II Synthesis Essay Assignment Summer Semester 2017.docx
College Writing II Synthesis Essay Assignment Summer Semester 2017.docx
 

Mehr von inemet

EUFEPS and European Initiatives in Pharmaceutical Sciences
EUFEPS and European Initiatives in Pharmaceutical SciencesEUFEPS and European Initiatives in Pharmaceutical Sciences
EUFEPS and European Initiatives in Pharmaceutical Sciencesinemet
 
Legal requirements for generics and abridged products and bioequivalence
Legal requirements for generics and abridged products and bioequivalenceLegal requirements for generics and abridged products and bioequivalence
Legal requirements for generics and abridged products and bioequivalenceinemet
 
The role of dissolution in the demonstration of bioequivalence
The role of dissolution in the demonstration of bioequivalenceThe role of dissolution in the demonstration of bioequivalence
The role of dissolution in the demonstration of bioequivalenceinemet
 
Future trends and perspectives in modern pharmaceutical biotechnology
Future trends and perspectives in modern pharmaceutical biotechnologyFuture trends and perspectives in modern pharmaceutical biotechnology
Future trends and perspectives in modern pharmaceutical biotechnologyinemet
 
Focussing on cytotoxic treatment alone is not enough
Focussing on cytotoxic treatment alone is not enoughFocussing on cytotoxic treatment alone is not enough
Focussing on cytotoxic treatment alone is not enoughinemet
 
Bioavailability and bioequivalence – problems and pitfalls
Bioavailability and bioequivalence – problems and pitfallsBioavailability and bioequivalence – problems and pitfalls
Bioavailability and bioequivalence – problems and pitfallsinemet
 
Quo Vadis EU Pharmacy?
Quo Vadis EU Pharmacy?Quo Vadis EU Pharmacy?
Quo Vadis EU Pharmacy?inemet
 
Education - Do we have a choice?
Education - Do we have a choice?Education - Do we have a choice?
Education - Do we have a choice?inemet
 
The truth between the lines – Community pharmacists in improving the health o...
The truth between the lines – Community pharmacists in improving the health o...The truth between the lines – Community pharmacists in improving the health o...
The truth between the lines – Community pharmacists in improving the health o...inemet
 
BY HELPING PEOPLE MY DREAM IS BECOMING TRUE
BY HELPING PEOPLE MY DREAM IS BECOMING TRUEBY HELPING PEOPLE MY DREAM IS BECOMING TRUE
BY HELPING PEOPLE MY DREAM IS BECOMING TRUEinemet
 
POSTGENETICS MEDICINE
POSTGENETICS MEDICINEPOSTGENETICS MEDICINE
POSTGENETICS MEDICINEinemet
 
SHARING VISION – TOWARDS BIOMEDICINE PARTNERS
SHARING VISION – TOWARDS BIOMEDICINE PARTNERSSHARING VISION – TOWARDS BIOMEDICINE PARTNERS
SHARING VISION – TOWARDS BIOMEDICINE PARTNERSinemet
 
Sightseeing Pharmacy practice - The way forward
Sightseeing Pharmacy practice - The way forwardSightseeing Pharmacy practice - The way forward
Sightseeing Pharmacy practice - The way forwardinemet
 
EU telematics in the regulation of pharmaceuticals
EU telematics in the regulation of pharmaceuticalsEU telematics in the regulation of pharmaceuticals
EU telematics in the regulation of pharmaceuticalsinemet
 
Generics and Biogenerics
Generics and BiogenericsGenerics and Biogenerics
Generics and Biogenericsinemet
 
Pharmacovigilance Workshop
Pharmacovigilance WorkshopPharmacovigilance Workshop
Pharmacovigilance Workshopinemet
 
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...inemet
 
Making knowledge matter: The Skills Inventory and the Competency Maps
Making knowledge matter: The Skills Inventory and the Competency MapsMaking knowledge matter: The Skills Inventory and the Competency Maps
Making knowledge matter: The Skills Inventory and the Competency Mapsinemet
 
Trigger Point – Self-medication: Patients in white coats
Trigger Point – Self-medication: Patients in white coats Trigger Point – Self-medication: Patients in white coats
Trigger Point – Self-medication: Patients in white coats inemet
 
Pharmacy in croatia - A short overview
Pharmacy in croatia - A short overviewPharmacy in croatia - A short overview
Pharmacy in croatia - A short overviewinemet
 

Mehr von inemet (20)

EUFEPS and European Initiatives in Pharmaceutical Sciences
EUFEPS and European Initiatives in Pharmaceutical SciencesEUFEPS and European Initiatives in Pharmaceutical Sciences
EUFEPS and European Initiatives in Pharmaceutical Sciences
 
Legal requirements for generics and abridged products and bioequivalence
Legal requirements for generics and abridged products and bioequivalenceLegal requirements for generics and abridged products and bioequivalence
Legal requirements for generics and abridged products and bioequivalence
 
The role of dissolution in the demonstration of bioequivalence
The role of dissolution in the demonstration of bioequivalenceThe role of dissolution in the demonstration of bioequivalence
The role of dissolution in the demonstration of bioequivalence
 
Future trends and perspectives in modern pharmaceutical biotechnology
Future trends and perspectives in modern pharmaceutical biotechnologyFuture trends and perspectives in modern pharmaceutical biotechnology
Future trends and perspectives in modern pharmaceutical biotechnology
 
Focussing on cytotoxic treatment alone is not enough
Focussing on cytotoxic treatment alone is not enoughFocussing on cytotoxic treatment alone is not enough
Focussing on cytotoxic treatment alone is not enough
 
Bioavailability and bioequivalence – problems and pitfalls
Bioavailability and bioequivalence – problems and pitfallsBioavailability and bioequivalence – problems and pitfalls
Bioavailability and bioequivalence – problems and pitfalls
 
Quo Vadis EU Pharmacy?
Quo Vadis EU Pharmacy?Quo Vadis EU Pharmacy?
Quo Vadis EU Pharmacy?
 
Education - Do we have a choice?
Education - Do we have a choice?Education - Do we have a choice?
Education - Do we have a choice?
 
The truth between the lines – Community pharmacists in improving the health o...
The truth between the lines – Community pharmacists in improving the health o...The truth between the lines – Community pharmacists in improving the health o...
The truth between the lines – Community pharmacists in improving the health o...
 
BY HELPING PEOPLE MY DREAM IS BECOMING TRUE
BY HELPING PEOPLE MY DREAM IS BECOMING TRUEBY HELPING PEOPLE MY DREAM IS BECOMING TRUE
BY HELPING PEOPLE MY DREAM IS BECOMING TRUE
 
POSTGENETICS MEDICINE
POSTGENETICS MEDICINEPOSTGENETICS MEDICINE
POSTGENETICS MEDICINE
 
SHARING VISION – TOWARDS BIOMEDICINE PARTNERS
SHARING VISION – TOWARDS BIOMEDICINE PARTNERSSHARING VISION – TOWARDS BIOMEDICINE PARTNERS
SHARING VISION – TOWARDS BIOMEDICINE PARTNERS
 
Sightseeing Pharmacy practice - The way forward
Sightseeing Pharmacy practice - The way forwardSightseeing Pharmacy practice - The way forward
Sightseeing Pharmacy practice - The way forward
 
EU telematics in the regulation of pharmaceuticals
EU telematics in the regulation of pharmaceuticalsEU telematics in the regulation of pharmaceuticals
EU telematics in the regulation of pharmaceuticals
 
Generics and Biogenerics
Generics and BiogenericsGenerics and Biogenerics
Generics and Biogenerics
 
Pharmacovigilance Workshop
Pharmacovigilance WorkshopPharmacovigilance Workshop
Pharmacovigilance Workshop
 
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...
 
Making knowledge matter: The Skills Inventory and the Competency Maps
Making knowledge matter: The Skills Inventory and the Competency MapsMaking knowledge matter: The Skills Inventory and the Competency Maps
Making knowledge matter: The Skills Inventory and the Competency Maps
 
Trigger Point – Self-medication: Patients in white coats
Trigger Point – Self-medication: Patients in white coats Trigger Point – Self-medication: Patients in white coats
Trigger Point – Self-medication: Patients in white coats
 
Pharmacy in croatia - A short overview
Pharmacy in croatia - A short overviewPharmacy in croatia - A short overview
Pharmacy in croatia - A short overview
 

Kürzlich hochgeladen

The Economic History of the U.S. Lecture 17.pdf
The Economic History of the U.S. Lecture 17.pdfThe Economic History of the U.S. Lecture 17.pdf
The Economic History of the U.S. Lecture 17.pdfGale Pooley
 
VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...
VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...
VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...Call Girls in Nagpur High Profile
 
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...shivangimorya083
 
Log your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaignLog your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaignHenry Tapper
 
00_Main ppt_MeetupDORA&CyberSecurity.pptx
00_Main ppt_MeetupDORA&CyberSecurity.pptx00_Main ppt_MeetupDORA&CyberSecurity.pptx
00_Main ppt_MeetupDORA&CyberSecurity.pptxFinTech Belgium
 
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130 Available With Room
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130  Available With RoomVIP Kolkata Call Girl Jodhpur Park 👉 8250192130  Available With Room
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130 Available With Roomdivyansh0kumar0
 
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawl
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service AizawlVip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawl
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawlmakika9823
 
Q3 2024 Earnings Conference Call and Webcast Slides
Q3 2024 Earnings Conference Call and Webcast SlidesQ3 2024 Earnings Conference Call and Webcast Slides
Q3 2024 Earnings Conference Call and Webcast SlidesMarketing847413
 
Independent Call Girl Number in Kurla Mumbai📲 Pooja Nehwal 9892124323 💞 Full ...
Independent Call Girl Number in Kurla Mumbai📲 Pooja Nehwal 9892124323 💞 Full ...Independent Call Girl Number in Kurla Mumbai📲 Pooja Nehwal 9892124323 💞 Full ...
Independent Call Girl Number in Kurla Mumbai📲 Pooja Nehwal 9892124323 💞 Full ...Pooja Nehwal
 
High Class Call Girls Nashik Maya 7001305949 Independent Escort Service Nashik
High Class Call Girls Nashik Maya 7001305949 Independent Escort Service NashikHigh Class Call Girls Nashik Maya 7001305949 Independent Escort Service Nashik
High Class Call Girls Nashik Maya 7001305949 Independent Escort Service NashikCall Girls in Nagpur High Profile
 
How Automation is Driving Efficiency Through the Last Mile of Reporting
How Automation is Driving Efficiency Through the Last Mile of ReportingHow Automation is Driving Efficiency Through the Last Mile of Reporting
How Automation is Driving Efficiency Through the Last Mile of ReportingAggregage
 
Dharavi Russian callg Girls, { 09892124323 } || Call Girl In Mumbai ...
Dharavi Russian callg Girls, { 09892124323 } || Call Girl In Mumbai ...Dharavi Russian callg Girls, { 09892124323 } || Call Girl In Mumbai ...
Dharavi Russian callg Girls, { 09892124323 } || Call Girl In Mumbai ...Pooja Nehwal
 
03_Emmanuel Ndiaye_Degroof Petercam.pptx
03_Emmanuel Ndiaye_Degroof Petercam.pptx03_Emmanuel Ndiaye_Degroof Petercam.pptx
03_Emmanuel Ndiaye_Degroof Petercam.pptxFinTech Belgium
 
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...Suhani Kapoor
 
Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...
Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...
Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...makika9823
 
The Economic History of the U.S. Lecture 21.pdf
The Economic History of the U.S. Lecture 21.pdfThe Economic History of the U.S. Lecture 21.pdf
The Economic History of the U.S. Lecture 21.pdfGale Pooley
 
Solution Manual for Principles of Corporate Finance 14th Edition by Richard B...
Solution Manual for Principles of Corporate Finance 14th Edition by Richard B...Solution Manual for Principles of Corporate Finance 14th Edition by Richard B...
Solution Manual for Principles of Corporate Finance 14th Edition by Richard B...ssifa0344
 
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance Company
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance CompanyInterimreport1 January–31 March2024 Elo Mutual Pension Insurance Company
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance CompanyTyöeläkeyhtiö Elo
 
Lundin Gold April 2024 Corporate Presentation v4.pdf
Lundin Gold April 2024 Corporate Presentation v4.pdfLundin Gold April 2024 Corporate Presentation v4.pdf
Lundin Gold April 2024 Corporate Presentation v4.pdfAdnet Communications
 

Kürzlich hochgeladen (20)

The Economic History of the U.S. Lecture 17.pdf
The Economic History of the U.S. Lecture 17.pdfThe Economic History of the U.S. Lecture 17.pdf
The Economic History of the U.S. Lecture 17.pdf
 
VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...
VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...
VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...
 
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...
Russian Call Girls In Gtb Nagar (Delhi) 9711199012 💋✔💕😘 Naughty Call Girls Se...
 
Log your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaignLog your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaign
 
00_Main ppt_MeetupDORA&CyberSecurity.pptx
00_Main ppt_MeetupDORA&CyberSecurity.pptx00_Main ppt_MeetupDORA&CyberSecurity.pptx
00_Main ppt_MeetupDORA&CyberSecurity.pptx
 
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130 Available With Room
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130  Available With RoomVIP Kolkata Call Girl Jodhpur Park 👉 8250192130  Available With Room
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130 Available With Room
 
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawl
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service AizawlVip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawl
Vip B Aizawl Call Girls #9907093804 Contact Number Escorts Service Aizawl
 
Q3 2024 Earnings Conference Call and Webcast Slides
Q3 2024 Earnings Conference Call and Webcast SlidesQ3 2024 Earnings Conference Call and Webcast Slides
Q3 2024 Earnings Conference Call and Webcast Slides
 
Independent Call Girl Number in Kurla Mumbai📲 Pooja Nehwal 9892124323 💞 Full ...
Independent Call Girl Number in Kurla Mumbai📲 Pooja Nehwal 9892124323 💞 Full ...Independent Call Girl Number in Kurla Mumbai📲 Pooja Nehwal 9892124323 💞 Full ...
Independent Call Girl Number in Kurla Mumbai📲 Pooja Nehwal 9892124323 💞 Full ...
 
High Class Call Girls Nashik Maya 7001305949 Independent Escort Service Nashik
High Class Call Girls Nashik Maya 7001305949 Independent Escort Service NashikHigh Class Call Girls Nashik Maya 7001305949 Independent Escort Service Nashik
High Class Call Girls Nashik Maya 7001305949 Independent Escort Service Nashik
 
How Automation is Driving Efficiency Through the Last Mile of Reporting
How Automation is Driving Efficiency Through the Last Mile of ReportingHow Automation is Driving Efficiency Through the Last Mile of Reporting
How Automation is Driving Efficiency Through the Last Mile of Reporting
 
Dharavi Russian callg Girls, { 09892124323 } || Call Girl In Mumbai ...
Dharavi Russian callg Girls, { 09892124323 } || Call Girl In Mumbai ...Dharavi Russian callg Girls, { 09892124323 } || Call Girl In Mumbai ...
Dharavi Russian callg Girls, { 09892124323 } || Call Girl In Mumbai ...
 
03_Emmanuel Ndiaye_Degroof Petercam.pptx
03_Emmanuel Ndiaye_Degroof Petercam.pptx03_Emmanuel Ndiaye_Degroof Petercam.pptx
03_Emmanuel Ndiaye_Degroof Petercam.pptx
 
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...
VIP Call Girls LB Nagar ( Hyderabad ) Phone 8250192130 | ₹5k To 25k With Room...
 
Commercial Bank Economic Capsule - April 2024
Commercial Bank Economic Capsule - April 2024Commercial Bank Economic Capsule - April 2024
Commercial Bank Economic Capsule - April 2024
 
Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...
Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...
Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...
 
The Economic History of the U.S. Lecture 21.pdf
The Economic History of the U.S. Lecture 21.pdfThe Economic History of the U.S. Lecture 21.pdf
The Economic History of the U.S. Lecture 21.pdf
 
Solution Manual for Principles of Corporate Finance 14th Edition by Richard B...
Solution Manual for Principles of Corporate Finance 14th Edition by Richard B...Solution Manual for Principles of Corporate Finance 14th Edition by Richard B...
Solution Manual for Principles of Corporate Finance 14th Edition by Richard B...
 
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance Company
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance CompanyInterimreport1 January–31 March2024 Elo Mutual Pension Insurance Company
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance Company
 
Lundin Gold April 2024 Corporate Presentation v4.pdf
Lundin Gold April 2024 Corporate Presentation v4.pdfLundin Gold April 2024 Corporate Presentation v4.pdf
Lundin Gold April 2024 Corporate Presentation v4.pdf
 

Significance of BA/BE studies in drug research and evaluation of different aspects

  • 1.
  • 2. PRACTICAL ASPECTS of BIOEQUIVALENCE STUDIES For the TUFTAD Session: BA/BE The Proof of Concept Prof.Dr.A. Atilla HINCAL Hacettepe University Faculty of Pharmacy Sıhhiye 06100 Ankara,Turkey International Congress “PharmaCon2007”on New Technologies&Trends in Pharmaceutical Industry and Education, Dubrovnik,Croatia, May 22-27, 2007 This session is sponsored by
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11. BA/BE studies organization platform SPONSOR (Manufacturer) CLINICAL STUDIES (Accredited Centers, Analytical CRO’s) BIOANALYTICAL STUDIES (Accredited Centers, Analytical CRO’s) SCIENTIFIC CONTRACT SERVICE ORGANIZATION HEALTH AUTHORITY LOCAL ETHICAL COMMITTEE Candidate Product for BE CENTRAL ETHICAL COMMITTEE
  • 12.
  • 13.
  • 14.
  • 15. Conclusion 3 CSO s and CROs that have long time experience have cumulated knowledge and talent for a specific project management in BE studies. It is possible for such an experienced and established CSO/CRO to reduce the expenses of the sponsor pharmaceutical company, to avoid loss of sources and to optimize the use of time.
  • 16.
  • 18.